Media
Latest News
Washington, D.C. – Congressman Gus Bilirakis (R-FL), member of the Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade, today questioned witnesses regarding the failure of Takata airbags and the recall of millions of vehicles in the United States.
Washington, D.C. – Congressman Gus Bilirakis (R-FL), member of the Energy and Commerce Subcommittee on Health, tomorrow will be delivering a keynote speech for The Hill's A Discussion on Biosimilars, Patient Access & Affordability.
Washington, D.C. – Representative Gus Bilirakis (R-FL), member of the Energy and Commerce Health Committee, was named to serve on the Subcommittee on Health, the Subcommittee on Communications & Technology, and the Subcommittee on Commerce, Manufacturing, & Trade.
Washington, D.C. – Representative Gus Bilirakis (R-FL) is honored to join State Senator Simpson, State Representative Corcoran, State Representative Burgess and the Kiwanis Foundation to host a Holiday Farm Share Food Giveaway for those in need on December 6, 2014.
Washington, D.C. – Representative Gus Bilirakis, member of the House Energy and Commerce Committee, today led a letter to Environmental Protection Agency (EPA) Administrator McCarthy, joined by other Florida Republicans, to oppose the ramifications the proposed carbon emissions rule for Existing Electric Utility Generating Units, also known as the Clean Power Plan (CPP), will have on Floridians across the state.
U.S. Rep. Gus Bilirakis has introduced H.R. 5750 to Congress, known as the Orphan Product Extensions Now Accelerating Cures & Treatment — or the OPEN ACT.
The bill would incentivize drug makers and innovators to repurpose major market drugs for life-threatening, rare diseases and pediatric cancers, the Palm Harbor Republican said, which would open the door to development of hundreds of treatments for rare disease patients.
Washington, D.C. – Representative Gus Bilirakis, member of the House Energy and Commerce Subcommittee on Health, today introduced H.R. 5750, the Orphan Product Extensions Now Accelerating Cures & Treatments (OPEN ACT). The OPEN ACT will incentivize drug makers and innovators to "repurpose" major market drugs for life-threatening rare diseases and pediatric cancers, which opens the door to the development of hundreds of safe, effective, and affordable treatments for rare disease patients.
U.S. Rep. Gus Bilirakis, R-Fla., the vice chairman of the House Committee on Veterans Affairs, testified in front of the House Veterans Affairs Subcommittee on Health on Wednesday about giving veterans more medical choices. Bilirakis showcased his "Creating Options for Veterans' Expedited Recovery (COVER) Act" in his testimony which includes alternative therapies in VA care.
Washington, D.C. – Representative Gus Bilirakis, Vice-Chairman of the House Committee on Veterans Affairs, today testified before the House Veterans Affairs Subcommittee on Health about his bill, the Creating Options for Veterans' Expedited Recovery (COVER) Act. Bilirakis' bipartisan legislation will establish a commission to examine VA's current therapy model and the potential benefits in incorporating complementary alternative therapies.
Washington, D.C. – Representative Gus Bilirakis issued the following statement on the Obama Administration's decision to move forward with Executive Action on immigration:
"As a second generation Greek American, I have a firsthand understanding of the importance and power of the American dream, as well as the sensitivity and passion surrounding immigration reform. There is no doubt our immigration system is broken, but President Obama cannot act unilaterally and refuse to work with Congress. In the President's own words: ‘That's not how our democracy functions.'